N-able’s fair value estimate has been trimmed from $7.35 to $6.95, a reduction of about 5.4% that reflects a more cautious ...
Long-acting RNA interference therapy for hypertension could shift blood pressure control from daily pill-taking to scheduled, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results